FINDMED
Share
The objective of the FINDMED Consortium is to contribute to strengthening the competitiveness of the French pharmaceutical industry by facilitating access to academic research and technological resources.
Curie Cancer is founder and executive member.
Curie Cancer is founder and executive member.
Institut Curie has joined forces with 10 other Carnot institutes to create the FINDMED Consortium. The aim is to contribute to strengthening the competitiveness of the French pharmaceutical industry by facilitating access to academic research and technological resources.
To achieve this objective, FINDMED is implementing different actions:
- Structuring the offer of our high-level technological platforms that can provide solutions for pharmaceutical companies.
- Meeting potential industrial partners to identify their innovation needs.
- Linking companies with the academic platforms of the members of the consortium to establish partnerships.
Share